AstraZeneca to buy U.S.-based CinCor Pharma in $1.8 billion deal
(Reuters) - AstraZeneca said on Monday it will acquire U.S.-based clinical-stage biopharmaceutical company CinCor Pharma Inc in a deal valued at about $1.8 billion.…